BioCorRx Inc. | Cash Flow
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
3,838.50
3,127.80
4,666.00
5,904.00
29,705.70
6,584.40
Depreciation, Depletion & Amortization
135.50
135.50
125.10
30.20
33.90
7.40
Other Funds
57.30
95.60
-
-
-
4,623.50
Funds from Operations
924.00
793.60
520.30
1,537.30
2,324.70
1,953.50
Changes in Working Capital
1,027.50
961.30
568.10
449.80
219.90
127.90
Net Operating Cash Flow
103.50
167.70
47.90
1,987.10
2,544.60
1,825.60
Capital Expenditures
6.70
0.50
-
328.20
3.00
Net Investing Cash Flow
34.70
32.90
-
328.20
3.00
Issuance/Reduction of Debt, Net
91.10
99.60
119.10
2,137.70
1,476.50
Net Financing Cash Flow
33.80
190.20
119.10
2,237.70
2,416.50
Net Change in Cash
102.60
55.40
166.90
77.60
131.10
Free Cash Flow
96.80
167.20
47.90
2,009.70
2,547.60
Change in Capital Stock
-
5.00
-
100.00
940.00
Other Uses
28.10
32.40
-
-
-
About BioCorRx
View Profile
